Adding 2mL creates 50mg/mL for smaller injection volumes
Conclusion: A Dual Path With Encouraging Direction GHK-Cu's unique dual-track regulatory path topical from Category 1 and injectable from Category 2, both heading to PCAC review before February 2027 reflects the complexity and nuance of the FDA's current approach to peptide regulation
Longer term For longer repeated exposure, copper-related labs may be reviewed periodically with a clinician
Hand Hygiene: Before handling the syringe, needle, or vial, thoroughly wash your hands with soap and water, or use an alcohol-based hand sanitiser to reduce the risk of introducing contaminants
This makes it particularly effective for comprehensive anti-aging approaches
Whenever I come across a story that challenges conventional thinking about aging, I'll share it